Literature DB >> 31636748

Appropriate Surgical Treatment of Symptomatic Primary Varicose Veins Decreases Systemic Inflammatory Biomarkers.

Hiroki Arase1, Noriko Sugasawa1, Youhei Kawatani1, Mikio Sugano1, Hirotsugu Kurobe1, Eiki Fujimoto1, Takashi Kitaichi1, Tetsuya Kitagawa1.   

Abstract

Objective: To evaluate the relationship between systemic inflammatory biomarkers and efficacy of surgical treatment of primary varicose veins of the lower extremities.
Methods: Total 12 patients who underwent endovenous laser ablation or stripping of varicose veins and six healthy subjects were enrolled. Structural and molecular changes of varices were assessed by immunohistochemical staining with anti-monocyte chemotactic protein-1 (MCP-1). MCP-1 and interleukin-6 (IL-6) levels in systemic antecubital blood were measured before and at 12 weeks after treatment.
Results: Immunohistochemical staining revealed prominent manifestation of MCP-1-positive endothelial cells in the walls of varices. Preoperative serum MCP-1 and IL-6 levels in the patients were significantly higher than those in the control (166±12 pg/mL vs 99±10 pg/mL, p=0.003; 5.1±0.95 pg/mL vs 0.0±0.0 pg/mL, p=0.001, respectively). The values were significantly correlated with the severity of chronic venous insufficiency (CVI). Postoperative serum MCP-1 level significantly decreased compared with the preoperative level (152±10 pg/mL vs 166±12 pg/mL, p=0.048). The values after endovenous laser ablation did not significantly decrease compared with those after stripping.
Conclusion: Varicose veins with CVI increase inflammatory biomarker levels in the local tissue and systemic blood. Appropriate treatment of symptomatic varicose veins decreases inflammatory biomarker levels.
Copyright © 2019 Annals of Vascular Diseases.

Entities:  

Keywords:  IL-6; MCP-1; endovenous laser ablation; inflammatory biomarkers; varicose vein

Year:  2019        PMID: 31636748      PMCID: PMC6766771          DOI: 10.3400/avd.oa.19-00011

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  11 in total

Review 1.  Chronic venous disease.

Authors:  John J Bergan; Geert W Schmid-Schönbein; Philip D Coleridge Smith; Andrew N Nicolaides; Michel R Boisseau; Bo Eklof
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

Review 2.  Molecular mechanisms in chronic venous insufficiency.

Authors:  John Bergan
Journal:  Ann Vasc Surg       Date:  2007-05       Impact factor: 1.466

3.  Are Inflammatory Biomarkers Increased in Varicose Vein Blood?

Authors:  Christopher R Lattimer; Evi Kalodiki; George Geroulakos; Debra Hoppensteadt; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2016-04-21       Impact factor: 2.389

4.  Do blood constituents in varicose veins differ from the systemic blood constituents?

Authors:  P Poredos; A Spirkoska; T Rucigaj; J Fareed; M K Jezovnik
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-06-19       Impact factor: 7.069

5.  Functional polymorphism rs1024611 in the MCP1 gene is associated with the risk of varicose veins of lower extremities.

Authors:  Alexandra S Shadrina; Mariya A Smetanina; Kseniya S Sevost'ianova; Evgenii I Seliverstov; Evgeny A Ilyukhin; Elena N Voronina; Igor A Zolotukhin; Maxim L Filipenko
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2017-02-20

6.  Leukocyte activation in patients with venous insufficiency.

Authors:  S Takase; G Schmid-Schönbein; J J Bergan
Journal:  J Vasc Surg       Date:  1999-07       Impact factor: 4.268

7.  Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.

Authors:  A Schepers; D Eefting; P I Bonta; J M Grimbergen; M R de Vries; V van Weel; C J de Vries; K Egashira; J H van Bockel; P H A Quax
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-07-06       Impact factor: 8.311

Review 8.  Biomolecular mechanisms in varicose veins development.

Authors:  Oliwia Anna Segiet; Marlena Brzozowa-Zasada; Adam Piecuch; Damian Dudek; Edyta Reichman-Warmusz; Romuald Wojnicz
Journal:  Ann Vasc Surg       Date:  2014-10-30       Impact factor: 1.466

9.  Varicose veins show enhanced chemokine expression.

Authors:  L del Rio Solá; M Aceves; A I Dueñas; J A González-Fajardo; C Vaquero; M Sanchez Crespo; C García-Rodríguez
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-09-02       Impact factor: 7.069

10.  Varicose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors.

Authors:  Johannes Eschrich; Ralph Meyer; Hanna Kuk; Andreas H Wagner; Thomas Noppeney; Sebastian Debus; Markus Hecker; Thomas Korff
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.